{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:24:28Z","timestamp":1769829868067,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10147-011-0256-9","type":"journal-article","created":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T02:52:28Z","timestamp":1305687148000},"page":"155-159","source":"Crossref","is-referenced-by-count":12,"title":["Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib"],"prefix":"10.1007","volume":"17","author":[{"given":"Satoshi","family":"Tetsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Osa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako","family":"Kuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Goya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"256_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103\u2013119","journal-title":"Cancer Treat Rev"},{"key":"256_CR2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cncr.21033","volume":"103","author":"AM Omuro","year":"2005","unstructured":"Omuro AM, Kris MG, Miller VA et al (2005) High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 103:2344\u20132348","journal-title":"Cancer"},{"key":"256_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3816\/CLC.2004.n.026","volume":"6","author":"Y Namba","year":"2004","unstructured":"Namba Y, Kijima T, Yokota S et al (2004) Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 6:123\u2013128","journal-title":"Clin Lung Cancer"},{"key":"256_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3816\/CLC.2005.n.030","volume":"7","author":"A Gurpide","year":"2005","unstructured":"Gurpide A, Perez-Gracia JL, Lopez-Picazo JM et al (2005) Activity of gefitinib in central nervous system metastases in patients with non-small-cell lung cancer: two case reports and a review of the literature. Clin Lung Cancer 7:138\u2013140","journal-title":"Clin Lung Cancer"},{"key":"256_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1470-2045(01)00622-2","volume":"3","author":"IJ Fidler","year":"2002","unstructured":"Fidler IJ, Yano S, Zhang RD et al (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53\u201357","journal-title":"Lancet Oncol"},{"key":"256_CR6","first-page":"2474","volume":"42","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Leavens M, Maor M et al (1982) Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42:2474\u20132479","journal-title":"Cancer Res"},{"key":"256_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1023\/A:1008318515795","volume":"10","author":"PE Postmus","year":"1999","unstructured":"Postmus PE, Smit EF (1999) Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10:753\u2013759","journal-title":"Ann Oncol"},{"key":"256_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-5002(98)00021-X","volume":"20","author":"V Minotti","year":"1998","unstructured":"Minotti V, Crino L, Meacci ML et al (1998) Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 20:93\u201398","journal-title":"Lung Cancer"},{"key":"256_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1081\/CNV-120001173","volume":"20","author":"G Bernardo","year":"2002","unstructured":"Bernardo G, Cuzzoni Q, Strada MR et al (2002) First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study. Cancer Invest 20:293\u2013302","journal-title":"Cancer Invest"},{"key":"256_CR10","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2006.06.6126","volume":"24","author":"DM Jackman","year":"2006","unstructured":"Jackman DM, Holmes AJ, Lindeman N et al (2006) Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. J Clin Oncol 24:4517\u20134520","journal-title":"J Clin Oncol"},{"key":"256_CR11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1078-0432.CCR-06-2372","volume":"13","author":"A Broniscer","year":"2007","unstructured":"Broniscer A, Panetta JC, O\u2019Shaughnessy M et al (2007) Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420. Clin Cancer Res 13:1511\u20131515","journal-title":"Clin Cancer Res"},{"key":"256_CR12","doi-asserted-by":"crossref","unstructured":"Togashi Y, Masago K, Fukudo M et al (2010) Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer. J Thorac Oncol 5:950\u2013955","DOI":"10.1097\/JTO.0b013e3181e2138b"},{"key":"256_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lungcan.2008.10.016","volume":"65","author":"HG Yi","year":"2009","unstructured":"Yi HG, Kim HJ, Kim YJ et al (2009) Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI. Lung Cancer 65:80\u201384","journal-title":"Lung Cancer"},{"key":"256_CR14","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/JTO.0b013e3181b62572","volume":"4","author":"T Katayama","year":"2009","unstructured":"Katayama T, Shimizu J, Suda K et al (2009) Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 4:1415\u20131419","journal-title":"J Thorac Oncol"},{"key":"256_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ncponc0400","volume":"3","author":"NW Choong","year":"2006","unstructured":"Choong NW, Dietrich S, Seiwert TY et al (2006) Gefitinib response of erlotinib-refractory lung cancer involving meninges\u2014role of EGFR mutation. Nat Clin Pract Oncol 3:50\u201357","journal-title":"Nat Clin Pract Oncol"},{"key":"256_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/onc.2008.411","volume":"28","author":"Z Tang","year":"2009","unstructured":"Tang Z, Jiang S, Du R et al (2009) Disruption of the EGFR E884\u2013R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity. Oncogene 28:518\u2013533","journal-title":"Oncogene"},{"key":"256_CR17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2214\/ajr.176.6.1761585","volume":"176","author":"K Tsuchiya","year":"2001","unstructured":"Tsuchiya K, Katase S, Yoshino A et al (2001) FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis. Am J Roentgenol 176:1585\u20131588","journal-title":"Am J Roentgenol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0256-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0256-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0256-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:44:14Z","timestamp":1560203054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0256-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0256-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}